We are live on ! Find out more
NTGN

Neon Therapeutics, Inc. Common Stock
NTGN

Delisted

NTGN was delisted on the 5th of May, 2020.

Back to rankings

43 hedge funds and large institutions have $39.9M invested in Neon Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more capital invested

Capital invested by funds: $18.6M → $39.9M (+$21.3M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3.29% less ownership

Funds ownership: 55.69% → 52.4% (-3.3%)

7% less funds holding

Funds holding: 46 → 43 (-3)

21% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 14

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

Holders
43
Holders Change
-3
Holders Change %
-6.52%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
11
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$1.72M
2
AC
Athanor Capital
New York
+$898K
3
MS
Maven Securities
Jersey
+$625K
4
MGIA
Moneta Group Investment Advisors
Missouri
+$168K
5
State Street
State Street
Massachusetts
+$99.3K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.8M
2
AFM
Anson Funds Management
Texas
-$319K
3
FIA
FNY Investment Advisers
New York
-$295K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$222K
5
Millennium Management
Millennium Management
New York
-$197K

NTGN Hedge Fund Activity: Q1 2020 in Review

43 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Neon Therapeutics, Inc. Common Stock (NTGN) for Q1 2020, worth a combined $39.9M — up 114% from $18.6M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of NTGN and 9 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 11 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $1.72M. The largest seller was Fidelity Investments, exiting entirely with an estimated $1.8M sold.

  • 43 institutional investors held Neon Therapeutics, Inc. Common Stock (NTGN) as of Q1 2020, down from 46 in Q4 2019.
  • Funds reported $39.9M of Neon Therapeutics, Inc. Common Stock stock for Q1 2020, up 114% quarter-over-quarter.
  • 9 funds opened new Neon Therapeutics, Inc. Common Stock positions in Q1 2020 and 12 closed out, a net change of -3 holders.
  • The largest Neon Therapeutics, Inc. Common Stock buyer in Q1 2020 was Armistice Capital, an estimated $1.72M added.
  • The largest Neon Therapeutics, Inc. Common Stock seller in Q1 2020 was Fidelity Investments, an estimated $1.8M sold.

Based on aggregated 13F filings for Q1 2020.